Alliance for Cell Therapy Research Efforts

Through its Alliance for Cell Therapy Research, ACT Now is working to expand the evidence base for regenerative cell therapies through new forms of collaboration on clinical trials and advancing an outcomes database to promote collaborative evidence development.

Multiple activities are taking place under the guidance and leadership of the Alliance for Cell Therapy Research Advisory Board including the following:

  • Tracking of clinical research involving the use of regenerative medicine and cell therapies (RMCTs), beginning with COVID-19;
  • Design, development, and engagement of academic and medical institutions in a large-scale, multi-center, randomized, placebo-controlled clinical trial to evaluate the safety and efficacy of RMCTs for COVID-19, which has since received approval of an IND from the FDA.
  • Development and launch of an outcomes database–or registry–to capture outcomes from multiple clinical studies involving the use of RMCTs for patients with COVID-19.